4.7 Article

Discovery of Aryl Benzoyl Hydrazide Derivatives as Novel Potent Broad-Spectrum Inhibitors of Influenza A Virus RNA-Dependent RNA Polymerase (RdRp)

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 65, 期 5, 页码 3814-3832

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.1c01257

关键词

-

资金

  1. National Key R&D Program of China [2020YFA0908800]
  2. NSFC [32188101, 81971976, 81772236, 81773557, 81573279]
  3. Major Project of Technology Innovation Program of Hubei Province [2018ACA123]
  4. Fundamental Research Funds for the Central Universities of China [2042021kf1033]

向作者/读者索取更多资源

Influenza A viruses have a high antigenic shift and there are limited approved anti-influenza drugs available. Therefore, developing novel anti-influenza drugs is crucial for clinical treatment and prevention of influenza outbreaks. This study reports a series of novel aryl benzoyl hydrazide analogs that exhibit potent inhibitory activity against influenza A viruses. Compound 11q shows strong inhibitory activity against avian H5N1 flu strain, H1N1 virus, and Flu B virus, and possesses good oral bioavailability and inhibitory activity against influenza A virus in a mouse model.
Influenza A viruses possess a high antigenic shift, and the approved anti-influenza drugs are extremely limited, which makes the development of novel anti-influenza drugs for the clinical treatment and prevention of influenza outbreaks imperative. Herein, we report a series of novel aryl benzoyl hydrazide analogs as potent anti-influenza agents. Particularly, analogs 10b, 10c, 10g, 11p, and 11q exhibited potent inhibitory activity against the avian H5N1 flu strain with EC50 values ranging from 0.009 to 0.034 mu M. Moreover, compound 11q exhibited nanomolar antiviral effects against both the H1N1 virus and Flu B virus and possessed good oral bioavailability and inhibitory activity against influenza A virus in a mouse model. Preliminary mechanistic studies suggested that these compounds exert anti-influenza virus effects mainly by interacting with the PB1 subunit of RNA-dependent RNA polymerase (RdRp). These results revealed that 11q has the potential to become a potent clinical candidate to combat seasonal influenza and influenza pandemics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据